ovarian cancer and the combined oral contraceptive pill

Last reviewed 01/2018

• the use of the combined oral contraceptive pill leads to a reduction in risk of ovarian cancer by up to 40%
• a review noted that "..evidence that COCs reduce the risk of ovarian and endometrial cancer, which could be discussed with patients whilst discussing breast cancer risk..."

Reference:

1. MeReC Bulletin (2006); 17(2):1-9.